Cleared Traditional

K904714 - CIBA CORNING ACS PROLACTIN IMMUNOASSAY

K904714 is an FDA 510(k) clearance for CIBA CORNING ACS PROLACTIN IMMUNOASSAY, manufactured by Ciba Corning Diagnostics Corp.. The device is a Class 1 Chemistry device with product code CFT cleared through the Traditional 510(k) pathway after a 20-day FDA review.

K904714 · Ciba Corning Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1990
Decision
20d
Days
Class 1
Risk

K904714 is an FDA 510(k) clearance for the CIBA CORNING ACS PROLACTIN IMMUNOASSAY. Classified as Radioimmunoassay, Prolactin (lactogen) (product code CFT), Class I - General Controls.

Submitted by Ciba Corning Diagnostics Corp. (East Walpole, US). The FDA issued a Cleared decision on November 7, 1990 after a review of 20 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1625 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ciba Corning Diagnostics Corp. devices

FDA 510(k) Submission Details - K904714

510(k) Number K904714 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 1990
Decision Date November 07, 1990
Days to Decision 20 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 88d · This submission: 20d
Pathway characteristics
Predicate-based equivalence.

CFT Device Classification - Class 1, General Controls

Product Code CFT Radioimmunoassay, Prolactin (lactogen)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1625
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CFT Radioimmunoassay, Prolactin (lactogen)

All 56
Devices cleared under the same product code (CFT) and FDA review panel - the closest regulatory comparables to K904714.
PROLACTIN ENZYME IMMUNOASSAY TEST KIT (MODIFIED)
K920345 · Medix Biotech, Inc. · Mar 1992
AMERLITE(TM) PROLACTIN-30 ASSAY, LAN.0086/2086
K914135 · Amersham Corp. · Feb 1992
OPUS(R) PROLACTIN TEST SYSTEM
K913280 · Pb Diagnostic Systems, Inc. · Aug 1991
AFFINITY PROLACTIN TEST SYSTEM
K902698 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Jul 1990
PROLACTIN (LACTOGEN) TEST SYSTEM
K901673 · Baxter Healthcare Corp · Jun 1990
COAT-A-COUNT PROLACTIN IRMA #:IKPR1, IKPR2
K901578 · Diagnostic Products Corp. · Apr 1990